4Hernalandez C, et al. Erythropoietin is expresse in the human retina and it is highly elevated in the vitreous fluid of patients with dia-betic macular edema. Diabetes Care 2006;29(9) :2028 -2033.
5Tong Z, Yang Z, et al : Promoterpo lymorphism of the erythro- poie Gene in severe diabetic eye and kidney complications. Proc Natl Acad USA 2008;105(19) :6998 -7003.
6REVITAL SHURTZ - SWIRSKI, et al. Involvement of Pe- ripheral Polymorphonuclear Leukocytes in Oxidative Stress and Inflam- mation in Type 2 Diabetic Patients DIABETES CARE 2001 ;24( 1 ) : 104 -110.
5Su Y,Shao G,Gao L,et al.RBC electrophoresis with discontinuous power supply-a newly established hemoglobin release test[J].Electrophoresis,2009,30(17):304 1-3043.
6Johansson BL,Borg K,Fernqvist-Forbes E,et al.Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes[J].Diabet Med,2000,17(3):181-189.
7Ido Y,Vindigni A,Chang K,et al.Prevention of vascular and neural dysfunction in diabetic rats by C-peptide[J].Science,1997,277(5325):563-566.
8Ekberg K,Brismar T,Johansson BL,et al.Amelioration of Sensory Nerve Dysfunction by C-peptide in Patients With Type 1 Diabetes[J].Diabetes,2003,52(2):536-541.
10The Diabetes Control and Comlication Trial Reserch Group.The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus[J].N Engl J Med,1993,329(14):977-986.
